A cosmesis outcome substudy in a prospective, randomized trial comparing radioguided seed localization with standard wire localization for nonpalpable, invasive, and in situ breast carcinomas

Am J Surg. 2014 Nov;208(5):711-718. doi: 10.1016/j.amjsurg.2014.05.030. Epub 2014 Aug 5.

Abstract

Background: The primary study objective was to compare the cosmetic result of radioguided seed localization (RSL) with wire localization (WL).

Methods: A subgroup of patients enrolled in a multicentered, randomized trial comparing WL with RSL participated. Frontal photographs were taken 1 and 3 years postsurgery. The European Organization for Research and Treatment of Cancer Cosmetic Rating System was used to evaluate cosmesis outcomes by the patient and a panel of 5 raters.

Results: The study enrolled 73 patients (WL, n = 38; RSL, n = 35). Most patients rated their overall cosmesis as "excellent" or "good" (76% WL, 80% RSL). Patient and panel ratings on all cosmetic outcomes were similar between groups. Multivariable regression for overall cosmesis found larger specimen volume and reoperation to be predictors of worse ratings.

Conclusions: All cosmetic outcomes assessed were similar after WL and RSL. The comparable outcomes may reflect similar reoperation rates and volumes of excision between groups.

Keywords: Breast conserving surgery; Breast shape; Cosmetic outcome; Needle localization; Patient ratings.

Publication types

  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Breast Neoplasms / diagnostic imaging
  • Breast Neoplasms / surgery*
  • Carcinoma, Ductal, Breast / diagnostic imaging
  • Carcinoma, Ductal, Breast / surgery*
  • Carcinoma, Intraductal, Noninfiltrating / diagnostic imaging
  • Carcinoma, Intraductal, Noninfiltrating / surgery*
  • Esthetics*
  • Female
  • Follow-Up Studies
  • Humans
  • Iodine Radioisotopes / administration & dosage
  • Mastectomy, Segmental / instrumentation
  • Mastectomy, Segmental / methods*
  • Middle Aged
  • Prospective Studies
  • Radionuclide Imaging
  • Radiopharmaceuticals* / administration & dosage
  • Treatment Outcome

Substances

  • Iodine Radioisotopes
  • Radiopharmaceuticals